Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Proscar (finasteride) blocks 5α-reductase in sea urchin ovaries and testes, suggesting potential treatment for androgen-related conditions.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Finasteride effectively treats male hair loss, improving growth and density.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Rats had lasting erectile problems after stopping a certain medication.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Hair loss drugs may cause sexual issues and infertility in men.

Finasteride may affect PNMT, causing side effects.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Two distinct pathways direct proteins to vacuoles in Arabidopsis, affecting root hair growth and protein targeting.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Certain drugs that block specific enzymes can help treat prostate diseases.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The method effectively measures drug impact on DHT levels in prostate treatments.

New compounds show promise as nonsteroidal treatments for hair loss.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.